An estimation of the population survival benefit of first-line chemotherapy and immunotherapy for breast cancer

被引：0
|
作者：
Delaney, G. P.
Do, V.
Ng, W.
Barton, M. B.
机构：
[1] Ingham Inst Appl Med Res, CCORE, Sydney, NSW, Australia
[2] Univ Sydney, Crown Princess Mary Canc Ctr Westmead, Sydney, NSW, Australia
[3] Univ NSW, Sydney, NSW, Australia
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.SABCS16-P5-14-11
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-14-11
引用
收藏
页数：2
相关论文
共 50 条
  • [1] AN ESTIMATION OF THE POPULATION SURVIVAL BENEFIT OF FIRST-LINE CHEMOTHERAPY FOR UPPER GASTROINTESTINAL CANCER
    Viet Do
    Weng Ng
    Delaney, Geoff P.
    Barton, Michael B.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2013, 9 : 148 - 148
  • [2] An estimation of population-based survival benefit of first-line chemotherapy for urological cancer
    Do, V.
    Ng, W.
    Jacob, S.
    Delaney, G.
    Barton, M.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S510 - S510
  • [3] AN EVIDENCED-BASED ESTIMATION OF THE POPULATION SURVIVAL BENEFIT OF FIRST-LINE CHEMOTHERAPY FOR GYNAECOLOGICAL CANCER.
    Do, V.
    Ng, W.
    Delaney, G. P.
    Barton, M. B.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 192 - 193
  • [4] An estimation of the population survival benefit of first-course chemotherapy and immunotherapy for leukemia
    Do, V.
    Jacob, S.
    Ng, W.
    Delaney, G. P.
    Barton, M. B.
    ANNALS OF ONCOLOGY, 2016, 27
  • [5] An estimation of the population-based survival benefit of first-line chemotherapy for adult primary malignant brain tumour
    Do, V.
    Jacob, S.
    Ng, W.
    Delaney, G. P.
    Barton, M. B.
    ANNALS OF ONCOLOGY, 2015, 26 : 34 - 35
  • [6] Lack of benefit of maintenance paclitaxel in first-line chemotherapy in metastatic breast cancer
    Gennari, Alessandra
    Amadori, Dino
    De Lena, Mario
    Nanni, Oriana
    Bruzzi, Paolo
    Lorusso, Vito
    Manzione, Luigi
    Conte, Pier Franco
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (24) : 3912 - 3918
  • [7] Addition of Capecitabine in Breast Cancer First-line Chemotherapy Improves Survival of Breast Cancer Patients
    Xu, Di
    Chen, Xiu
    Li, Xingjiang
    Mao, Zhixiang
    Tang, Wenjuan
    Zhang, Wei
    Ding, Li
    Tang, Jinhai
    JOURNAL OF CANCER, 2019, 10 (02): : 418 - 429
  • [8] First-Line Chemotherapy for Metastatic Breast Cancer
    Telli, Melinda L.
    Carlson, Robert W.
    CLINICAL BREAST CANCER, 2009, 9 : S66 - S72
  • [9] Impact of cachexia on survival before first-line chemotherapy for metastatic breast cancer
    Nozawa, Kazuki
    Isogai, Ayaka
    Takatsuka, Daiki
    Endo, Yuka
    Ozaki, Yuri
    Horisawa, Nanae
    Kataoka, Ayumi
    Kotani, Haruru
    Yoshimura, Akiyo
    Hattori, Masaya
    Sawaki, Masataka
    Iwata, Hiroji
    ANNALS OF ONCOLOGY, 2022, 33 : S491 - S492
  • [10] First-line chemotherapy plus immunotherapy in biliary tract cancer
    Neuzillet, Cindy
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (06): : 496 - 497
12345